The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending vibegron (Obgemsa, Pierre Fabre) for treating overactive bladder (OAB) syndrome in adults. The ...

LAS VEGAS -- Overactive bladder (OAB) symptoms in women improved rapidly and significantly following a single treatment with transvaginal radiofrequency (RF) nerve ablation, a small prospective study ...

Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...

Compared with controls, the prevalence of metabolic syndrome (MetS) was higher among those with overactive bladder (OAB). Among MetS parameters, obesity was the strongest factor associated with OAB.

OAB is commonly treated with a class of medicines called anticholinergics or antimuscarinics. These medicines block chemicals in your body that help the bladder to squeeze. By blocking these chemicals ...

One in six adults have bladder control problems. It can disrupt sleep or cause accidents, lead to social isolation and depression and affects women more than men. Overactive bladder syndrome affects ...

A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...

Bladder leaks can be disruptive—and they’re very common. Up to 30 percent of older adults experience incontinence. The problem is more prevalent in women, but the percentage of men with an overactive ...

Please provide your email address to receive an email when new articles are posted on . Patients with overactive bladder had an odds ratio of 1.4 for osteoarthritis. Overactive bladder was not ...

Women treated with antimuscarinics for overactive bladder syndrome are more likely to be diagnosed with depression after treatment onset than overactive bladder patients not treated with the ...